Letrozole better than tamoxifen in postmenopausal women

被引：6
|
作者：
Fricker, J
机构：
来源：
LANCET ONCOLOGY | 2005年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(05)01758-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [21] Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women
    Hiromi Tanii
    Yoshihisa Shitara
    Toshiharu Horie
    [J]. European Journal of Clinical Pharmacology, 2011, 67 : 1017 - 1025
  • [22] Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women
    Tanii, Hiromi
    Shitara, Yoshihisa
    Horie, Toshiharu
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (10) : 1017 - 1025
  • [23] Letrozole is more cost-effective than tamoxifen as early adjuvant therapy in multiple sub-groups of postmenopausal women with early breast cancer: the UK perspective.
    Karnon, J.
    Kaura, S.
    Ditrapani, F.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S230 - S230
  • [24] Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
    Mouridsen, Henning
    Giobbie-Hurder, Anita
    Goldhirsch, Aron
    Thuerlimann, Beat
    Paridaens, Robert
    Smith, Ian
    Mauriac, Louis
    Forbes, John F.
    Price, Karen N.
    Regan, Meredith M.
    Gelber, Richard D.
    Coates, Alan S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 766 - 776
  • [25] Tamoxifen: '10 years is better than 5'
    Fricker, Janet
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (05) : 632 - 632
  • [26] Tamoxifen better than arzoxifene in breast cancer
    Sharma, Sharon Prakash
    [J]. LANCET ONCOLOGY, 2007, 8 (12): : 1058 - 1058
  • [27] Cost effectiveness analysis of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer
    Hashem, I.
    Al-Sherbini, M.
    El-Bary, N. Abd
    Swiha, M.
    [J]. BREAST, 2009, 18 : S78 - S78
  • [28] Zolandronic acid protective effect on bone loss in postmenopausal women switched from tamoxifen to letrozole in the treatment of early breast cancer
    Safra, T.
    Bernstein, R.
    Stephansky, I
    Yaal-Hahoshen, N.
    Inbar, M.
    Ackerstein, A.
    Geffen, D.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 152S - 152S
  • [29] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial
    Ribi, K. E.
    Phillips, K. A.
    Sun, Z.
    Stephens, A.
    Thompson, A.
    Harvey, V.
    Thuerlimann, B.
    Cardoso, F.
    Coates, A. S.
    Bernhard, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] SYMPTOMS ASSOCIATED WITH TAMOXIFEN TREATMENT IN POSTMENOPAUSAL WOMEN
    LOVE, RR
    CAMERON, L
    CONNELL, BL
    LEVENTHAL, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (09) : 1842 - 1847
12345